1417421-99-8

Basic information

• Product Name: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine
• Synonyms: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine;3-bromo-5-fluoro-1-(p-tolylsulfonyl)pyrrolo[2,3-b]pyridine;EOS-60354
• CAS NO: 1417421-99-8
• Molecular Formula: C₁₄H₁₀BrFN₂O₂S
• Molecular Weight: 369.2088032
• Mol File: 1417421-99-8.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• Density: 1.73g/cm3 at 20℃
• Vapor Pressure: 0-0Pa at 20-25℃
• CAS DataBase Reference: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine(1417421-99-8)
• EPA Substance Registry System: 3-bromo-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine(1417421-99-8)

Safety Data

• Hazardous Substances Data: 1417421-99-8(Hazardous Substances Data)

Upstream product

• 1190309-71-7 3-bromo-5-fluoro-1H-pyrrolo-[2,3-b]pyridine 
• 98-59-9 p-toluenesulfonyl chloride 
• 866319-01-9 5-fluoro-3-(2-trimethylsilylethynyl)pyridine-2-amine 
• 866318-99-2 5-fluoro-1-tosyl-1H-pyrrolo [2,3-b]pyridine 
• 823218-51-5 5-fluoro-3-iodo-pyridin-2-amine 
• 21717-96-4 2-amino-5-fluoropyridine 
• 866319-00-8 5-fluoro-1H-pyrrolo[2,3‐b]pyridine 
• 936344-74-0 3-ethynyl-5-fluoro-pyridin-2-ylamine 
• 869557-43-7 3-bromo-5-fluoropyridin-2-amine 

Downstream Products

• 1422051-94-2 methyl (+/-)-3-cyclobutyl-3-((5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)propanoate 
• 1422051-96-4 (S)-2-(5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-ylamino)-3,3-dimethylbutan-1-ol 
• 1422051-97-5 (S)-2-(5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-ylamino)-3,3-dimethylbutyl methanesulfonate 
• 1422051-98-6 (S)-2-(5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-ylamino)-3,3-dimethylbutyl ethanethioate 
• 1422051-99-7 (S)-2-(5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3yl)pyrimidin-4-ylamino)-3,3-dimethylbutane-1-sulfonic acid 
• 1422052-00-3 (S)-2-(5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-ylamino)-3,3-dimethylbutane-1-sulfonyl chloride 
• 1422052-07-0 (S)-N-(3,3-dimethyl-1-(methylsulfonyl)butan-2-yl)-5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-amine 
• 1422051-75-9 (R)-methyl 3-((5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-4,4-dimethylpentanoate 
• 1422052-16-1 (S)-5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-((1-hydroxy-3,3-dimethylbutan-2-yl)amino)nicotinonitrile 
• 1422052-17-2 (S)-2-((5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-yl)amino)-3,3-dimethylbutyl methanesulfonate 
• 1422052-18-3 (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutyl ethanethiolate 
• 1422052-19-4 (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonic acid 
• 1422052-20-7 (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonyl chloride 
• 1422052-25-2 (+/-)-methyl 3-((5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-3-(1-methylcyclobutyl)propanoate 

Relevant articles and documents

ANTI-INFLUENZA VIRUS PYRIMIDINE DERIVATIVE

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

FORMULATIONS OF AZAINDOLE COMPOUNDS

The present invention relates to pharmaceutical compositions, each comprising a multitude of granules that make up an intragranular phase of the composition, wherein the granules are produced by fluid bed granulation and comprise a HCI salt of Compound (1

Novel heterocyclic compounds and medicinal application of same as anti-influenza virus inhibitors

The invention provides heterocyclic compounds represented by a formula (I) as described in the specification or a pharmaceutically acceptable salt thereof, a preparation method thereof, and application of the heterocyclic compounds to the preparation of m